Cardiff Oncology Inc. buy krebskrebs
Start price
16.10.23
/
50%
€1.08
Target price
16.10.24
€1.60
Performance (%)
135.62%
End price
17.10.24
€2.54
Summary
This prediction ended on 17.10.24 with a price of €2.54. With a performance of 135.62% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cardiff Oncology Inc. | 9.677% | 9.677% | -34.510% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by krebskrebs for this prediction
In the thread Trovagene diskutieren
In the thread Trading Trovagene
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten